Boston Scientific Corp (NYSE:BSX)

28.84
Delayed Data
As of Apr 20
 -0.05 / -0.17%
Today’s Change
24.54
Today|||52-Week Range
29.93
+16.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line----------
Funds From Operations----------
Funds From/For Other Operating Expenses----------
Net Cash Flow - Operating Activities114.0M185.0M255.0M872.0M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-47.0M-42.0M-42.0M
 
 
 
 
Capital Expenditures-112.0M-68.0M-60.0M-79.0M
 
 
 
 
 
Net Assets From Acquisitions ----0.00-168.0M
 
 
Other Investing - Uses-28.0M28.0M0.000.00
 
 
 
Net Cash Flow Investing-140.0M-479.0M-102.0M-289.0M
 
 
 
 
 
 
FinancingShort Term Borrowings----240.0M-70.0M
 
 
 
Long Term Borrowings1.0B1.1B0.000.00
 
 
 
Long Term Debt Reduction-985.0M-1.8B-400.0M0.00
 
 
 
 
Net Proceeds Stock Sale33.0M11.0M35.0M6.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing----------
Other Uses - Financing79.0M1.0M14.0M4.0M
 
 
 
 
 
Net Cash Flow - Financing-15.0M332.0M-139.0M-68.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.0M1.0M1.0M1.0M
 
 
 
 
 
 
Net Change In Cash-41.0M38.0M14.0M515.0M